Epizyme Story

Epizyme Inc -- USA Stock  

USD 19.75  1.00  5.33%

Macroaxis does not monitor all media channels or aggregates social signals for Epizyme. But even though we do not provide professional-grade financial sentiment analysis on Epizyme Inc, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Epizyme. Additionally see Epizyme Hype Analysis, Epizyme Correlation and Epizyme Performance
Acquisition by Michael Giordano of 25000 shares of Epizyme subject to Rule 16b-3
Filed transaction by Epizyme Inc director. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Epizyme Inc insider trading alert for grant of stock option (right to buy) by Michael Giordano, the corporate stakeholder, on March 12, 2018. This event was filed by Epizyme Inc with SEC on 2018-03-12. Statement of changes in beneficial ownership - SEC Form 4

Cash Floor Correlation

Click cells to compare fundamentals   View All Correlations

Story Momentum

This media report from MacroaxisInsider distributed on March 12, 2018 was a factor to the next trading day price appreciation.The overall trading delta against the next closing price was 3.25% . The overall trading delta when the story was published against the current closing price is 7.05% .

Similar stores for Epizyme

Wedbush Reaffirms Outperform Rating for Epizymenews
registrarjournal.comEtrade Financial Holder Argent Capital Management Trimmed Stake Epizyme Stock Rose While Nea ... NormanObserver.comFull coverage
few days ago at http://newburghgazette.com 
Crosslink Capital INC Has Raised Palo Alto Networks Stake
Newburgh GazetteFull coverage

Did you try this?

Run Fundamentals Comparison Now

Fundamentals Comparison

Compare fundamentals across multiple equities to find investing opportunities
Hide  View All  NextLaunch Fundamentals Comparison

Current Valuation

Current Valuation Comparative Analysis
  Current Valuation 
      Epizyme Comparables 
Epizyme is currently under evaluation in current valuation category among related companies. Enterprise Value is a firm valuation proxy that approximates current market value of a company. It is typically used to determine takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that company has on its balance sheet. When takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.